Jeff Thomis Appointed Chairman of the Board of IDIS

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Idis, a leading specialist in the creation of managed access programmes for medicines for healthcare professionals and their patients with unmet medical needs, today named Jeff Thomis as the Company’s Chairman.

The appointment is effective immediately. In his new role, Jeff will work with the Board and the leadership team in delivering the company’s future growth plans and meeting its goal of becoming the global authority in access to medicines worldwide.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC